$SYRUP I do believe still has huge underwritten growth potential.
50-100M ARR over the next 12 months is a reasonable target for protocol revenue. Loan booked increased by 500M over the last few weeks.
Remains one of the largest lenders to Institutions in the Industry. https://t.co/WVENp5Tv0R
